Skip to main content
. Author manuscript; available in PMC: 2009 Nov 1.
Published in final edited form as: Crit Care Med. 2008 Nov;36(11):3067–3073. doi: 10.1097/CCM.0b013e31818c6fb7

Figure 6.

Figure 6

C3H/HeJ (TLR4 mutation) and C3H/HeOuJ (TLR4 intact) mice were pretreated with PGN prior to challenge with live S. aureus. The mice were observed for mortality for 7 days after the challenge. Mice that were pretreated had significantly better survival after the S. aureus challenge than control mice. (p < 0.05, N = 10-11 per group)